{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:47:41Z","timestamp":1791002861911,"version":"4.1.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Tolerogenic dendritic cells (tolDC) are currently in clinical trials for the treatment of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The methods for producing therapeutic tolDC vary widely, with little being known about the commonalities and differences of distinct cell products in terms of their regulatory actions on CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. We compared human monocyte-derived tolDC generated with vitamin D3 alone or in combination with dexamethasone. We found marked differences in the surface expression of HLA-DR and immune regulatory molecules, but also found commonalities, e.g. a strongly reduced capacity to produce interleukin-12 and a concomitant decreased ability to induce interferon-\u03b3 secretion by allogeneic CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. To gain a deeper understanding of how these tolDC types exert their regulatory effects, we co-cultured them with CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells from rheumatoid arthritis patients or healthy controls and analysed the gene expression profile and function of the responding T cells. We found that tolDC generated with vitamin D3 alone, but not in combination with dexamethasone, induced potent cytotoxic activity in the responding CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells as demonstrated by an enhanced cytotoxic gene signature, increased levels of intracellular granzyme B, and superior cytotoxic activity towards myeloid and B cells. These data identify cytotoxicity as an atypical CD4\n                    <jats:sup>+<\/jats:sup>\n                    T helper cell effector function induced by some but not all tolDC types, with implications for their individual clinical applications.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1698413","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:10:19Z","timestamp":1766380219000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Human tolerogenic dendritic cell subtypes exert divergent effects on induction of cytotoxic CD4+ T cells"],"prefix":"10.3389","volume":"16","author":[{"given":"Gabrielle","family":"Barran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib","family":"Naamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Mannan","family":"Baru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Falconer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharien M. U.","family":"Hilkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltad012","article-title":"Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration","volume":"3","author":"Mansilla","year":"2023","journal-title":"Immunotherapy Adv"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.3390\/IJMS22168415","article-title":"Tolerogenic dendritic cell-based approaches in autoimmunity","volume":"22","author":"Passeri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/08830180903281193","article-title":"Development of dendritic cell-based immunotherapy for autoimmunity","volume":"29","author":"Hilkens","year":"2010","journal-title":"Int Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"14985","DOI":"10.1038\/s41598-018-33248-7","article-title":"Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin","volume":"8","author":"Navarro-Barriuso","year":"2018","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02062","article-title":"Searching for the transcriptomic signature of immune tolerance induction\u2014Biomarkers of safety and functionality for tolerogenic dendritic cells and regulatory macrophages","volume":"9","author":"Navarro-Barriuso","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2019.00181","article-title":"Ways forward for tolerance-inducing cellular therapies- an AFACTT perspective","volume":"10","author":"ten Brinke","year":"2019","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e030309","DOI":"10.1136\/BMJOPEN-2019-030309","article-title":"Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): A harmonised study protocol for two phase i clinical trials comparing intradermal and intranodal cell administration","volume":"9","author":"Willekens","year":"2019","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1107744","article-title":"Differential regulation of na\u00efve and memory CD4+ T cells by alternatively activated dendritic cells","volume":"84","author":"Anderson","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0608374","article-title":"LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells","volume":"85","author":"Anderson","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.126383","article-title":"Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis","volume":"69","author":"Harry","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12967-019-2128-4","article-title":"Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis","volume":"17","author":"Spiering","year":"2019","journal-title":"J Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.27756","article-title":"Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses","volume":"62","author":"Stoop","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02068","article-title":"Matured tolerogenic dendritic cells effectively inhibit autoantigen specific CD4+ T cells in a murine arthritis model","volume":"10","author":"Jansen","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e078231","DOI":"10.1136\/BMJOPEN-2023-078231","article-title":"Design of TOLERANT: phase I\/II safety assessment of intranodal administration of HSP70\/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis","volume":"14","author":"Stoppelenburg","year":"2024","journal-title":"BMJ Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1\u03b1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-89","article-title":"Comparative study of clinical grade human tolerogenic dendritic cells","volume":"9","author":"Naranjo-G\u00f3mez","year":"2011","journal-title":"J Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2044","article-title":"Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3","volume":"106","author":"Penna","year":"2005","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.075","article-title":"Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells","volume":"32","author":"Bakdash","year":"2014","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12342","article-title":"Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis","volume":"21","author":"Mansilla","year":"2015","journal-title":"CNS Neurosci Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12974-016-0584-9","article-title":"Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients","volume":"13","author":"Mansilla","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12776","article-title":"1,25-dihydroxyvitamin D3-induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells","volume":"152","author":"Xie","year":"2017","journal-title":"Immunology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12974-019-1541-1","article-title":"Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA","volume":"16","author":"Derdelinckx","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.2300\/SUPP-3","article-title":"Minimum information about tolerogenic antigen-presenting cells (MITAP): A first step towards reproducibility and standardisation of cellular therapies","volume":"2016","author":"Lord","year":"2016","journal-title":"PeerJ"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3135-5_31","article-title":"In vitro generation of human tolerogenic monocyte-derived dendritic cells","volume-title":"The Immune Synapse: Methods and Protocols","author":"Hilkens","year":"2023"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac762","article-title":"Easy NanoString nCounter data analysis with the NanoTube","volume":"39","author":"Class","year":"2023","journal-title":"Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"research0034.1","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"060012","DOI":"10.1101\/060012","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5392623","article-title":"Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on dendritic cells promote induction of T cell hyporesponsiveness to myelin-derived antigens","volume":"2016","author":"Lee","year":"2016","journal-title":"J Immunol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3A0714-334R","article-title":"MERTK as negative regulator of human T cell activation","volume":"97","author":"Cabez\u00f3n","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS242115903\/S1","article-title":"The tolerogenic influence of dexamethasone on dendritic cells is accompanied by the induction of efferocytosis, promoted by MERTK","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.5.2790","article-title":"Recombinant ig-like transcript 3-fc modulates T cell responses via induction of th anergy and differentiation of CD8+ T suppressor cells1","volume":"176","author":"Kim-Schulze","year":"2006","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/39614","article-title":"A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2019","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004030050144","article-title":"Cytokines and their effects on maturation, differentiation and migration of dendritic cells","volume":"289","author":"Jonuleit","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.6.2804","article-title":"Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ Dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation1","volume":"161","author":"Kalin\u00edski","year":"1998","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells1","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e178949","DOI":"10.1172\/JCI178949","article-title":"Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis","volume":"134","author":"Fondelli","year":"2024","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2010.12.002","article-title":"Foxo transcription factors control regulatory T cell development and function","volume":"33","author":"Kerdiles","year":"2010","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081242","article-title":"Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs","volume":"206","author":"Cruz-Guilloty","year":"2009","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3410","article-title":"A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet","volume":"17","author":"Xin","year":"2016","journal-title":"Nat Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e30496","DOI":"10.7554\/eLife.30496","article-title":"The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes","volume":"7","author":"Serroukh","year":"2018","journal-title":"Elife"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ni807","article-title":"Hlx is induced by and genetically interacts with T-bet to promote heritable TH1 gene induction","volume":"3","author":"Mullen","year":"2002","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2024.1392535","article-title":"Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials","volume":"15","author":"Thompson","year":"2024","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1137918","article-title":"Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1046\/J.1365-2249.1999.00881.X","article-title":"The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA)","volume":"116","author":"Tak","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412001200","article-title":"Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin","volume":"280","author":"Buzza","year":"2005","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/RHEUMATOLOGY\/40.1.55","article-title":"Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis","volume":"40","author":"Ronday","year":"2001","journal-title":"Rheumatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3450","article-title":"Interleukin 21-induced granzyme b-expressing b cells infiltrate tumors and regulate t cells","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2009-07-235382","article-title":"Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion","volume":"115","author":"Jahrsd\u00f6rfer","year":"2010","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.599623","article-title":"Vitamin D3-induced tolerogenic dendritic cells modulate the transcriptomic profile of T CD4+ Cells towards a functional hyporesponsiveness","volume":"11","author":"Navarro-Barriuso","year":"2021","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864748","article-title":"Cytolytic CD4+ and CD8+ Regulatory T-cells and implications for developing immunotherapies to combat graft-versus-host disease","volume":"13","author":"Bolivar-Wagers","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/308365a0","article-title":"Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture","volume":"308","author":"Fleischer","year":"1984","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(86)90071-6","article-title":"Allospecific proliferative human T-cell clones acquire the cytotoxic effector function after three months in culture, in IL-2 conditioned medium","volume":"17","author":"Chen","year":"1986","journal-title":"Hum Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cellimm.2009.03.002","article-title":"IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells","volume":"257","author":"Brown","year":"2009","journal-title":"Cell Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.2.752","article-title":"Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor","volume":"91","author":"Ray","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110244","article-title":"Vitamin D receptor, STAT3, and TET2 cooperate to establish tolerogenesis","volume":"38","author":"Catal\u00e0-Moll","year":"2022","journal-title":"Cell Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02123-15","article-title":"Cytomegalovirus-specific CD4 T cells are cytolytic and mediate vaccine protection","volume":"90","author":"Verma","year":"2015","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01461-13","article-title":"Cytokine-Dependent Induction of CD4+ T cells with Cytotoxic Potential during Influenza Virus Infection","volume":"87","author":"Laiqing","year":"2013","journal-title":"J Virol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951900","article-title":"When helpers go above and beyond: development and characterization of cytotoxic CD4+ T cells","volume":"13","author":"Hoeks","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2017.01160","article-title":"Cytotoxic CD4+ T cells drive multiple sclerosis progression","volume":"8","author":"Peeters","year":"2017","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2017.00195","article-title":"Expansions of cytotoxic CD4+CD28- T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection","volume":"8","author":"Broadley","year":"2017","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.06.003","article-title":"Pathogenic features of CD4+CD28\u2013 T cells in immune disorders","volume":"18","author":"Broux","year":"2012","journal-title":"Trends Mol Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.11.006","article-title":"CX3CR1 drives cytotoxic CD4+CD28\u2013 T cells into the brain of multiple sclerosis patients","volume":"38","author":"Broux","year":"2012","journal-title":"J Autoimmun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e81455","DOI":"10.1371\/journal.pone.0081455","article-title":"CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation","volume":"8","author":"Ruck","year":"2013","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202725","article-title":"Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis","volume":"190","author":"Zaguia","year":"2013","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"Proc Natl Acad Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1698413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T05:10:20Z","timestamp":1766380220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1698413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2025.1698413"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1698413","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"article-number":"1698413"}}